首页> 外文期刊>中国癌症研究(英文版) >Inhibitory Effects of 5-Aza-2'-Deoxycytidine and Trichostatin A in Combination with p53-Expressing Adenovirus on Human Laryngocarcinoma Cells
【24h】

Inhibitory Effects of 5-Aza-2'-Deoxycytidine and Trichostatin A in Combination with p53-Expressing Adenovirus on Human Laryngocarcinoma Cells

机译:5-Aza-2'-脱氧胞苷和曲古抑素A联合表达p53的腺病毒对人喉癌细胞的抑制作用

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To investigate the effects of 5-Aza-2'-deoxycytidine (5-Aza-Cdr) and trichostatin A (TSA) combined with p53-expressing adenovirus (Ad-p53) on Hep-2 cell line in vivo and in vitro,in order to explore its possibility in biological treatment of laryngocarcinoma.Methods:Effects of 5-Aza-Cdr and TSA in combination with Ad-p53 on Hep-2 cell line in vivo were determined by Cell Counting Kit-8 (CCK-8) assay.The effect of drug combination was calculated by Jin's formula.Effects on the cell line in vitro were investigated by establishing the nude mice model.Results:5-Aza-Cdr and TSA showed inhibitory effects on the proliferation of Hep-2 cells in dose-and timedependent manner.Ad-p53 can inhibit the growth of Hep-2 cells in vivo and in vitro.However,the combination of epigenetic reagents (5-Aza-Cdr/TSA) and Ad-p53 was less effective than individual use of Ad-p53.5-Aza-Cdr and Adp53 inhibited the growth of transplanted tumors and reduced the volume of tumors,and the tumor volume of Ad-p53 group was significantly smaller than that of the control group (P<0.05).Conclusion:Both epigenetic reagents (5-Aza-Cdr/TSA) and Ad-p53 can suppress cell proliferation on Hep-2 in vivo and in vitro and there may be some antagonistic mechanism between Ad-p53 and epigenetic reagents (5-Aza-Cdr/TSA).
机译:目的:探讨5-Aza-2'-脱氧胞苷(5-Aza-Cdr)和曲古抑菌素A(TSA)联合表达p53的腺病毒(Ad-p53)对Hep-2细胞株的体内外影响方法:用细胞计数试剂盒8(CCK-8)测定5-Aza-Cdr和TSA联合Ad-p53对Hep-2细胞株体内的影响。结果显示:5-Aza-Cdr和TSA对Hep-2细胞的增殖有抑制作用,用金氏公式计算药物结合的作用,通过建立裸鼠模型研究其对体外细胞系的影响。 Ad-p53可以在体内和体外抑制Hep-2细胞的生长。但是,表观遗传试剂(5-Aza-Cdr / TSA)和Ad-p53的联合使用效果不佳。 Ad-p53.5-Aza-Cdr和Adp53的使用可抑制移植瘤的生长,减少肿瘤的体积,降低Ad-p5的肿瘤体积3组显着小于对照组(P <0.05)。结论:表观遗传试剂(5-Aza-Cdr / TSA)和Ad-p53均可抑制Hep-2细胞在体内外的增殖。可能是Ad-p53与表观遗传试剂(5-Aza-Cdr / TSA)之间的某种拮抗机制。

著录项

  • 来源
    《中国癌症研究(英文版)》 |2012年第3期|232-237|共6页
  • 作者单位

    Key Laboratory of Otorhinolaryngology Head and Neck Surgery(Ministry of Education), Beijing Institute of Otorhinolaryngology,Beijing 100005, China;

    Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University,Beijing 100730, China;

    Key Laboratory of Otorhinolaryngology Head and Neck Surgery(Ministry of Education), Beijing Institute of Otorhinolaryngology,Beijing 100005, China;

    Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University,Beijing 100730, China;

    Key Laboratory of Otorhinolaryngology Head and Neck Surgery(Ministry of Education), Beijing Institute of Otorhinolaryngology,Beijing 100005, China;

    Key Laboratory of Otorhinolaryngology Head and Neck Surgery(Ministry of Education), Beijing Institute of Otorhinolaryngology,Beijing 100005, China;

    Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University,Beijing 100730, China;

    Key Laboratory of Otorhinolaryngology Head and Neck Surgery(Ministry of Education), Beijing Institute of Otorhinolaryngology,Beijing 100005, China;

    Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University,Beijing 100730, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号